LLY stock, Novo Nordisk to dominate Obesity despite Amgen entry (NYSE:LLY) | Seeking Alpha
Anti-obesity drug shows promise in trials - RTHK
Amgen's AMG-133 shows potential in competing with GLP-1RA obesity therapies - Pharmaceutical Technology
Dr Reddy's to market three Amgen drugs in India - The Hindu BusinessLine
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits | Fierce Pharma
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power | Fierce Biotech
Startup founder's extreme reverse-aging routine • Horizon-Amgen deal faces resistance • Abbott device OK'd for diabetic nerve pain | Crain's Chicago Business
Amgen says experimental obesity drug shows promising durability | Al Arabiya English
Amgen avoids 'low hanging fruit' in tackling undruggable targets
Johnson & Johnson: J&J sues Amgen over plan to sell drug similar to blockbuster Stelara, Health News, ET HealthWorld
Tavneos Developer ChemoCentryx to be Acquired by Amgen for Almost $4 Billion - Xtalks
Amgen to push latecomer obesity drug into midstage testing | pharmaphorum
Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs - MedCity News
Amgen says experimental obesity drug has promising durability | Reuters
Pricing pressure weighs on Amgen as Lumakras declines
Amgen takes back three drugs from GSK - Clinical Professionals
Amgen pledges $1.9bn to alliance with AI specialist Generate | Pharmaphorum
Array BioPharma and Amgen Partner in Type 2 Diabetes| Amgen
J&J, Amgen, Regeneron Drugs Likely to Face Medicare Negotiation (1)
Pharma News and Updates | Lilly, Amgen, Roche, Pfizer, Civica, Nacto
How did Amgen Korea make key drugs reimbursable so quickly? < Pharma < Article - KBR
Amgen Gains FDA Approval for Parsabiv - Drug Discovery and Development
![PDF] New Drugs in Development for the Treatment of Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c1bff0fb4e34f11d36c83fe57262fb362d87c9d3/3-Table2-1.png "PDF] New Drugs in Development for the Treatment of Diabetes | Semantic Scholar")
PDF] New Drugs in Development for the Treatment of Diabetes | Semantic Scholar
New Drugs for the Treatment of Heart Failure | USC Journal
Bear-faced lie? Amgen retracts diabetes paper due to data manipulation
Mirati challenges Amgen with FDA okay for KRAS drug | pharmaphorum
Biotech firm Amgen says experimental obesity drug has promising durability | The Straits Times
Reddy: Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in India - The Economic Times
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst | Fierce Pharma
